280 related articles for article (PubMed ID: 16124837)
1. Major depressive disorder in children and adolescents: clinical trial design and antidepressant efficacy.
Emslie GJ; Ryan ND; Wagner KD
J Clin Psychiatry; 2005; 66 Suppl 7():14-20. PubMed ID: 16124837
[TBL] [Abstract][Full Text] [Related]
2. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?
Berk M; Dodd S
Med Hypotheses; 2005; 65(1):39-43. PubMed ID: 15893115
[TBL] [Abstract][Full Text] [Related]
3. The contribution of pharmacoepidemiology to the antidepressant-suicidality debate in children and adolescents.
Bridge JA; Axelson DA
Int Rev Psychiatry; 2008 Apr; 20(2):209-14. PubMed ID: 18386214
[TBL] [Abstract][Full Text] [Related]
4. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.
Bridge JA; Birmaher B; Iyengar S; Barbe RP; Brent DA
Am J Psychiatry; 2009 Jan; 166(1):42-9. PubMed ID: 19047322
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants in child and adolescent depression: where are the bugs?
Moreno C; Arango C; Parellada M; Shaffer D; Bird H
Acta Psychiatr Scand; 2007 Mar; 115(3):184-95. PubMed ID: 17302618
[TBL] [Abstract][Full Text] [Related]
6. Suicide rates in short-term randomized controlled trials of newer antidepressants.
Hammad TA; Laughren TP; Racoosin JA
J Clin Psychopharmacol; 2006 Apr; 26(2):203-7. PubMed ID: 16633153
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of child and adolescent depression.
Moreno C; Roche AM; Greenhill LL
Child Adolesc Psychiatr Clin N Am; 2006 Oct; 15(4):977-98, x. PubMed ID: 16952771
[TBL] [Abstract][Full Text] [Related]
8. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
9. The risks and benefits of antidepressant treatment for youth depression.
Bridge JA; Salary CB; Birmaher B; Asare AG; Brent DA
Ann Med; 2005; 37(6):404-12. PubMed ID: 16203613
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Müller N; Schennach R; Riedel M; Möller HJ
Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in antidepressant therapy in special populations.
Hayes D
Am J Manag Care; 2004 Jul; 10(6 Suppl):S179-85. PubMed ID: 15354675
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.
Olfson M; Marcus SC; Shaffer D
Arch Gen Psychiatry; 2006 Aug; 63(8):865-72. PubMed ID: 16894062
[TBL] [Abstract][Full Text] [Related]
13. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
[TBL] [Abstract][Full Text] [Related]
14. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
Akiskal HS; Benazzi F
J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
[TBL] [Abstract][Full Text] [Related]
15. Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?
Weisberg HI; Hayden VC; Pontes VP
Clin Trials; 2009 Apr; 6(2):109-18. PubMed ID: 19342462
[TBL] [Abstract][Full Text] [Related]
16. No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline.
Roberts RL; Mulder RT; Joyce PR; Luty SE; Kennedy MA
Hum Psychopharmacol; 2004 Jan; 19(1):17-23. PubMed ID: 14716707
[TBL] [Abstract][Full Text] [Related]
17. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
Papakostas GI; Fava M
Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
[TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled studies in depression: necessary, ethical and feasible.
Baldwin D; Broich K; Fritze J; Kasper S; Westenberg H; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):22-8. PubMed ID: 12664309
[TBL] [Abstract][Full Text] [Related]
19. Nontricyclic antidepressants: current trends in children and adolescents.
Emslie GJ; Walkup JT; Pliszka SR; Ernst M
J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):517-28. PubMed ID: 10230183
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
